Authors: Hidalgo, M Aylesworth, C Hammond, LA Britten, CD Weiss, G Stephenson, J Schwartz, G Patnaik, A Smith, L Molpus, K Felton, S Gupta, E Ferrante, KJ Tortora, A Sonnichsen, DS Skillings, J Rowinsky, EK

Citation: M. Hidalgo et al., Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxel, J CL ONCOL, 19(9), 2001, pp. 2493-2503

Authors: Tolcher, AW Eckhardt, SG Kuhn, J Hammond, L Weiss, G Rizzo, J Aylesworth, C Hidalgo, M Patnaik, A Schwartz, G Felton, S Campbell, E Rowinsky, EK

Citation: Aw. Tolcher et al., Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory properties, J CL ONCOL, 19(11), 2001, pp. 2937-2947

Authors: Goedert, JI Fung, MM Felton, S Battjes, RJ Engels, EA

Citation: Ji. Goedert et al., Cause-specific mortality associated with HIV and HTLV-II infections among injecting drug users in the USA, AIDS, 15(10), 2001, pp. 1295-1302

Authors: Jonsson, PE Felton, S Svedlindh, P Nordblad, P Hansen, MF

Citation: Pe. Jonsson et al., Fragility of the spin-glass-like collective state to a magnetic field in an interacting Fe-C nanoparticle system - art. no. 212402, PHYS REV B, 6421(21), 2001, pp. 2402

Authors: Eckhardt, SG Baker, SD Britten, CD Hidalgo, M Siu, L Hammond, LA Villalona-Calero, MA Felton, S Drengler, R Kuhn, JG Clark, GM Smith, SL MacDonald, JR Smith, C Moczygemba, J Weitman, S Von Hoff, DD Rowinsky, EK

Citation: Sg. Eckhardt et al., Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies, J CL ONCOL, 18(24), 2000, pp. 4086-4097

Authors: Levine, PH Dosik, H Joseph, EM Felton, S Bertoni, MA Cervantes, J Moulana, V Miotti, AB Goberdhan, LJ Lee, SL Daouad, A DaCosta, M Jaffe, ES Axiotis, CA Cleghorn, FR Kahn, A Welles, SL

Citation: Ph. Levine et al., A study of adult T-cell leukemia/lymphoma incidence in central Brooklyn, INT J CANC, 80(5), 1999, pp. 662-666